Showing 2,961 - 2,980 results of 9,336 for search '"M.S."', query time: 0.07s Refine Results
  1. 2961
  2. 2962
  3. 2963
  4. 2964
  5. 2965

    Toxicity of volatile compounds of Senecio grisebachii BAKER (margarita) Flowers, in mice by P. Zeinsteger, A. Romero, P. Teibler, M. Montenegro, E. Rios, E. M. Ciotti, O. Acosta De Perez, N. Jorge

    Published 2003-01-01
    “…El extracto acuoso obtenido por destilación por arrastre con vapor de agua de flores frescas de Senecio grisebachii fue administrado por vía oral a ratones (0.5 mL/ratón/día) durante 30 días. Los animales fueron observados periódicamente. …”
    Get full text
    Article
  6. 2966
  7. 2967
  8. 2968
  9. 2969
  10. 2970
  11. 2971
  12. 2972
  13. 2973
  14. 2974
  15. 2975
  16. 2976

    HPLC and GC-MS analyses of phytochemicals from Ficus carica leaf extract and essential oil along with their antimicrobial properties by Maximilian Lackner, Abdelfattah Z.M. Salem, Mohamed Z.M. Salem, Abeer A. Mohamed, José Luis Ponce-Covarrubias, Shady Selim

    Published 2025-03-01
    “…The main phenolic compounds in the ACE were p-coumaric acid (13.63 μg/mL), ferulic acid (12.63 μg/mL), and caffeic acid (10.42 μg/mL), and the main flavonoid compounds were naringin (15.45 μg/mL), rutin (8.60 μg/mL), and luteolin (7.48 μg/mL). …”
    Get full text
    Article
  17. 2977

    TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms by Nicholas L. Calistri, Tiera A. Liby, Zhi Hu, Hongmei Zhang, Mark A. Dane, Sean M. Gross, Laura M. Heiser

    Published 2025-02-01
    “…We further explored the influence of these TFs on paclitaxel-induced cell cycle behavior via live cell imaging, which revealed altered progression rates through G1, S/G2 and M phases. We found that ELF3 knockdown synergized with paclitaxel treatment to lock cells in a G1 state and prevent cell cycle progression. …”
    Get full text
    Article
  18. 2978
  19. 2979
  20. 2980

    Principles of effective out-patient diagnostics of diffuse liver diseases by Komova A. G., M. V. Mayevskaya, V. T. Ivashkin

    Published 2014-11-01
    “…Risk factors for diseases, defined by one-way ANOVA test, were: male gender (p<0,001), excessive body weight and obesity (body mass index >25 kg/m2 (p<0,001)), hyperglycemia (p<0,001), hypertriglyceridemia (p<0,001). …”
    Get full text
    Article